Publications by authors named "Jena D French"

Claim this Profile
T
Tumor-infiltrating T Lymphocytes Recognize Thyroid-specific and Neo-antigens in Follicular Cell-derived Thyroid Cancers.
Breaunna Garza, Jacob Calhoun, Paul Norman, Noah Cline, Katherine M Kichula, Jena D French

J Clin Endocrinol Metab· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Loss of tumor cell MHC class II drives MAPK inhibitor insensitivity of BRAF-mutant anaplastic thyroid cancers.
Vera Tiedje, Jillian Greenberg, Tianyue Qin, Soo-Yeon Im, Gnana P Krishnamoorthy, Jena D French

J Clin Invest· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Loss of tumor cell MHC Class II drives insensitivity of BRAF-mutant anaplastic thyroid cancers to MAPK inhibitors.
Vera Tiedje, Jillian Greenberg, Tianyue Qin, Soo-Yeon Im, Gnana P Krishnamoorthy, Jena D French

bioRxiv· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combination Targeted Therapy with Pembrolizumab and Lenvatinib in Progressive, Radioiodine-Refractory Differentiated Thyroid Cancers.
Jena D French, Bryan R Haugen, Francis P Worden, Daniel W Bowles, Andrew G Gianoukakis

Clin Cancer Res· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lenvatinib Plus Anti-PD-1 Combination Therapy for Advanced Cancers: Defining Mechanisms of Resistance in an Inducible Transgenic Model of Thyroid Cancer.
Bruna C Bertol, Elise S Bales, Jacob D Calhoun, Alanna Mayberry, Melissa L Ledezma, Jena D French

Thyroid· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunotherapy for advanced thyroid cancers - rationale, current advances and future strategies.
Jena D French

Nat Rev Endocrinol· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comprehensive Immune Profiling of Medullary Thyroid Cancer.
Nikita Pozdeyev, Timothy A Erickson, Lian Zhang, Kim Ellison, Christopher J Rivard, Jena D French

Thyroid· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of an Adrenocortical Cancer Humanized Mouse Model to Characterize Anti-PD1 Effects on Tumor Microenvironment.
Julie Lang, Anna Capasso, Kimberly R Jordan, Jena D French, Adwitiya Kar

J Clin Endocrinol Metab· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genetic Analysis of 779 Advanced Differentiated and Anaplastic Thyroid Cancers.
Nikita Pozdeyev, Laurie M Gay, Ethan S Sokol, Ryan Hartmaier, Kelsi E Deaver, Jena D French

Clin Cancer Res· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Thyroid cancer: CAR T cell therapy - potential in advanced thyroid cancer?
Jena D French, Bryan R Haugen

Nat Rev Endocrinol· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Thyroid-Specific T Cells in Patients With Differentiated Thyroid Cancer: Implications for Immune-Based Therapies?
Jena D French, Bryan R Haugen

J Clin Endocrinol Metab· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Leveraging the immune system to treat advanced thyroid cancers.
Jena D French, Keith Bible, Christine Spitzweg, Bryan R Haugen, Mabel Ryder

Lancet Diabetes Endocrinol· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumor-Infiltrating T Cells and the PD-1 Checkpoint Pathway in Advanced Differentiated and Anaplastic Thyroid Cancer.
Jill J Bastman, Hilary S Serracino, Yuwen Zhu, Michelle R Koenig, Valerica Mateescu, Jena D French

J Clin Endocrinol Metab· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PD-1+Tim-3+ CD8+ T Lymphocytes Display Varied Degrees of Functional Exhaustion in Patients with Regionally Metastatic Differentiated Thyroid Cancer.
Jill J Severson, Hilary S Serracino, Valerica Mateescu, Christopher D Raeburn, Robert C McIntyre, Jena D French

Cancer Immunol Res· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Revisiting immune-based therapies for aggressive follicular cell-derived thyroid cancers.
Jena D French

Thyroid· May 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Influence of human immune cells on cancer: studies at the University of Colorado.
Tullia C Bruno, Jena D French, Kimberly R Jordan, Oscar Ramirez, Trisha R Sippel

Immunol Res· March 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Programmed death-1+ T cells and regulatory T cells are enriched in tumor-involved lymph nodes and associated with aggressive features in papillary thyroid cancer.
Jena D French, Gregory R Kotnis, Sherif Said, Christopher D Raeburn, Robert C McIntyre

J Clin Endocrinol Metab· June 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumor-associated lymphocytes and increased FoxP3+ regulatory T cell frequency correlate with more aggressive papillary thyroid cancer.
Jena D French, Zachary J Weber, Deborah L Fretwell, Sherif Said, Joshua P Klopper

J Clin Endocrinol Metab· May 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of Src with AZD0530 reveals the Src-Focal Adhesion kinase complex as a novel therapeutic target in papillary and anaplastic thyroid cancer.
Rebecca E Schweppe, Anna A Kerege, Jena D French, Vibha Sharma, Rachel L Grzywa

J Clin Endocrinol Metab· June 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gammadelta T lymphocyte homeostasis is negatively regulated by beta2-microglobulin.
Jena D French, Christina L Roark, Willi K Born, Rebecca L O'Brien

J Immunol· February 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exacerbation of collagen-induced arthritis by oligoclonal, IL-17-producing gamma delta T cells.
Christina L Roark, Jena D French, Molly A Taylor, Alison M Bendele, Willi K Born

J Immunol· October 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Airway hyperresponsiveness through synergy of gammadelta} T cells and NKT cells.
Niyun Jin, Nobuaki Miyahara, Christina L Roark, Jena D French, M Kemal Aydintug

J Immunol· September 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
gammadelta T lymphocytes-selectable cells within the innate system?
Willi K Born, Niyun Jin, M Kemal Aydintug, J M Wands, Jena D French

J Clin Immunol· March 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
gammadelta T-cell receptors: functional correlations.
Rebecca L O'Brien, Christina L Roark, Niyun Jin, M Kemal Aydintug, Jena D French

Immunol Rev· February 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
{
{gamma}{delta} T cell homeostasis is established in competition with {alpha}{beta} T cells and NK cells.
Jena D French, Christina L Roark, Willi K Born, Rebecca L O'brien

Proc Natl Acad Sci U S A· October 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis